Literature DB >> 15143935

Pancreatic cancer today.

Michael C Safioleas1, Konstantinos G Moulakakis.   

Abstract

Carcinoma of the exocrine pancreas remains a challenging disease with poor prognosis mainly due to advanced stage by the time of presentation, the early systemic dissemination and its extraordinary local tumor progression. Surgery has little more to offer in improvement of curative percentage of disease and some progress has been made in the medical management of pancreatic cancer with the introduction and use of new chemical agents and with combined immunochemotherapy and chemoradiotherapy. The purpose of this review article is to focus on all recent advances in the management of pancreatic cancer. We review the current trial literature emphasizing the risk factors, the molecular biology of the tumor, and the therapeutic approach.

Entities:  

Mesh：

Year:  2004        PMID： 15143935

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN： 0172-6390


  9 in total

1.  Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration.

Authors:  Peng Zhang; Zhiyong Guo; Ronglin Hu; Xiaoshun He; Xingyuan Jiao; Xiaofeng Zhu
Journal:  Tumour Biol       Date:  2015-07-08

Review 2.  DNA methylation based biomarkers in non-invasive cancer screening.

Authors:  N Shivapurkar; A F Gazdar
Journal:  Curr Mol Med       Date:  2010-03       Impact factor: 2.222

3.  Nanodelivery of Parthenolide Using Functionalized Nanographene Enhances its Anticancer Activity.

Authors:  A Karmakar; Y Xu; T Mustafa; G Kannarpady; S M Bratton; A Radominska-Pandya; P A Crooks; A S Biris
Journal:  RSC Adv       Date:  2015-01-01       Impact factor: 3.361

4.  Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro.

Authors:  Jun-Wei Liu; Min-Xia Cai; Ying Xin; Qing-Song Wu; Jun Ma; Po Yang; Hai-Yang Xie; Dong-Sheng Huang
Journal:  J Exp Clin Cancer Res       Date:  2010-08-10

5.  Occult tumor cells in lymph nodes as a predictor for tumor relapse in pancreatic adenocarcinoma.

Authors:  Peter Scheunemann; Nikolas H Stoecklein; Alexander Rehders; Minu Bidde; Sylvia Metz; Matthias Peiper; Claus F Eisenberger; Jan Schulte Am Esch; Wolfram T Knoefel; Stefan B Hosch
Journal:  Langenbecks Arch Surg       Date:  2007-08-18       Impact factor: 3.445

6.  Enjoy the Silence: The Story of let-7 MicroRNA and Cancer.

Authors:  Torrisani Jérôme; Parmentier Laurie; Buscail Louis; Cordelier Pierre
Journal:  Curr Genomics       Date:  2007-06       Impact factor: 2.236

7.  Single-walled carbon nanotube and graphene nanodelivery of gambogic acid increases its cytotoxicity in breast and pancreatic cancer cells.

Authors:  Lamya M Saeed; Meena Mahmood; Sebastian J Pyrek; Tariq Fahmi; Yang Xu; Thikra Mustafa; Zeid A Nima; Stacie M Bratton; Dan Casciano; Enkeleda Dervishi; Anna Radominska-Pandya; Alexandru S Biris
Journal:  J Appl Toxicol       Date:  2014-09-12       Impact factor: 3.446

8.  Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo.

Authors:  Beatrice Cousin; Emmanuel Ravet; Sandrine Poglio; Fabienne De Toni; Mélanie Bertuzzi; Hubert Lulka; Ismahane Touil; Mireille André; Jean-Louis Grolleau; Jean-Marie Péron; Jean-Pierre Chavoin; Philippe Bourin; Luc Pénicaud; Louis Casteilla; Louis Buscail; Pierre Cordelier
Journal:  PLoS One       Date:  2009-07-17       Impact factor: 3.240

9.  Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer.

Authors:  M Ohashi; K Yoshida; M Kushida; Y Miura; S Ohnami; Y Ikarashi; Y Kitade; T Yoshida; K Aoki
Journal:  Br J Cancer       Date:  2005-08-22       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.